State Street Corp Enochian Biosciences Inc Transaction History

State Street Corp

  • $2.47 Trillion
  • Q4 2024

A detailed history of State Street Corp transactions in Enochian Biosciences Inc stock. As of the latest transaction made, State Street Corp holds 2,064,859 shares of ENOB stock, worth $9.5 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,064,859
Previous 1,323,832 55.98%
Holding current value
$9.5 Million
Previous $6.09 Million 55.99%
% of portfolio
0.0%
Previous 0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025
BUY
N/A
741,027 Added 55.98%
2,064,859 $9.5 Million
Q3 2024

Nov 14, 2024
BUY
N/A
48,114 Added 3.77%
1,323,832 $6.09 Million
Q2 2024

Aug 14, 2024
BUY
N/A
1,178,031 Added 1205.92%
1,275,718 $5.87 Million
Q4 2023

Feb 14, 2024
BUY
$4.3 - $4.7 $147,490 - $161,210
34,300 Added 54.11%
97,687 $449,000
Q3 2023

Nov 14, 2023
BUY
$0.0 - $4.46 $0 - $50,398
11,300 Added 21.69%
63,387 $282,000
Q2 2023

Aug 14, 2023
SELL
$0.4 - $1.3 $102,128 - $331,917
-255,321 Reduced 83.06%
52,087 $29,000
Q1 2023

May 15, 2023
BUY
$0.91 - $1.31 $1,638 - $2,358
1,800 Added 0.59%
307,408 $282,000
Q4 2022

Feb 14, 2023
SELL
$1.03 - $2.13 $11,037 - $22,825
-10,716 Reduced 3.39%
305,608 $314,000
Q3 2022

Nov 15, 2022
SELL
$1.7 - $2.86 $246 - $414
-145 Reduced 0.05%
316,324 $573,000
Q2 2022

Aug 15, 2022
BUY
$1.93 - $8.73 $510,257 - $2.31 Million
264,382 Added 507.58%
316,469 $611,000
Q1 2022

May 16, 2022
BUY
$4.42 - $9.0 $16,778 - $34,164
3,796 Added 7.86%
52,087 $430,000
Q3 2021

Nov 15, 2021
BUY
$4.56 - $7.88 $70,680 - $122,140
15,500 Added 47.27%
48,291 $325,000
Q2 2021

Aug 16, 2021
SELL
$2.94 - $6.79 $456,820 - $1.06 Million
-155,381 Reduced 82.57%
32,791 $163,000
Q1 2021

May 17, 2021
BUY
$3.02 - $4.51 $906 - $1,353
300 Added 0.16%
188,172 $666,000
Q4 2020

Feb 16, 2021
SELL
$2.82 - $3.55 $13,254 - $16,685
-4,700 Reduced 2.44%
187,872 $554,000
Q3 2020

Nov 10, 2020
BUY
$3.42 - $4.55 $130,148 - $173,150
38,055 Added 24.63%
192,572 $689,000
Q2 2020

Aug 14, 2020
BUY
$2.78 - $6.06 $88,265 - $192,405
31,750 Added 25.86%
154,517 $651,000
Q1 2020

May 11, 2020
BUY
$2.08 - $5.41 $255,355 - $664,169
122,767 New
122,767 $368,000

Others Institutions Holding ENOB

# of Institutions
58
Shares Held
19M
Call Options Held
41.4K
Put Options Held
49.2K
View Full List

About Enochian Biosciences Inc

ENOB Quotes by TradingView
  • Ticker ENOB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 52,950,000
  • Market Cap $244M
  • Description
  • Enochian Biosciences, Inc., a pre-clinical stage biotechnology company, engages in the research and development of pharmaceutical and biological products for the human treatment of human immunodeficiency virus (HIV), hepatitis B virus (HBV), influenza and coronavirus infections, and cancer. The company's lead candidate includes ENOB-HV-01 for au...
More about ENOB
Track This Portfolio

Track State Street Corp Portfolio

Follow State Street Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email